SlideShare una empresa de Scribd logo
1 de 49
Descargar para leer sin conexión
Scheme of Presentation
Introduction
Historical Perspective
Epidemiology & Indian Scenario
Pathogenesis
Clinical features & Complications
Approach to the Disease
Management
Prevention & Control
SCRUB TYPHUS - Introduction
• Aka., Japanese river fever
• known in Japanese folklore to be associated with the jungle mite
or chigger, termed ‘tsutsugamushi’ in Japanese
• (tsutsuga = disease,harm, noxious and mushi = bug).
• is a zoonosis, with humans being accidental, dead
end hosts
Historical Perspective
• Rickettsial infection has been one of the great scourges of mankind,
occurring in devastating epidemics during times of war and famine.
• Hippocrates in 460 bc used the term typhus,
meaning ‘smoke’, to describe the ‘confused
state of the intellect – a tendency to stupor’
associated with high fevers.
Why is it linked to War ?
• Napoleon’s retreat from Moscow
was forced by rickettsial disease
breaking out among his troops.
• Lenin is said to have remarked, in
reference to rickettsial disease during
Russian revolution,“either socialism will
defeat the louse or the louse will defeat
the socialism”
Major Impact on research during WW2..
• Its impact on immunologically naive Allied
troops between 1942 and 1945 resulted in
18 000 cases and 639 deaths (4.0%), as
well as an estimated 20 000 cases in
Japanese troops.
• First batch of scrub typhus vaccine used
to inoculate human subjects was
dispatched to India for use by the Allied
Land Forces, South-East Asia Command,
in June 1945.
• Leading cause of pyrexia of unknown
origin (PUOs) in forces of USA during the
VietNam conflict.
Indian Scenario
• In India, the disease had occurred among troops
during the Second World War in Assam and West
Bengal, and in the 1965 Indo-Pak war.
• There was a resurgence of the disease in 1990 in a
unit of an army deployed at the Pakistan border of
India.
• Occurrence reported from several states in India
including Jammu and Kashmir, Himachal Pradesh,
Uttarakhand, Bihar, West Bengal, Meghalaya,
Rajasthan, Maharashtra, Karnataka, Tamil Nadu
and Kerala.
• Scrub typhus accounts for upto 50% of
undifferentiated fever presenting to hospitals.
• It remains a major underdiagnosed(suspected)
cause of undifferentiated fever.
TsuTsugamushi Triangle
South and Southeast
Asia,
the Asian Pacific rim,
Northern Australia
Geographic Distribution
The Rickettsial diseases
Modern classification based on whole-genome analysis…
Typhus
Group
•Epidemic Typhus - R.prowazekki
•Murine Typhus - R.typhi
•Scrub Typhus - O.tsutsugamushi
Spotted
Fever
Group
•Indian tick typhus - R.conorii
•Rocky Mountain spotted fever
•Rickettsial pox - R.akari
others
•Q Fever - C.brunetti
•Trench Fever - Rochalimaea Quintana
Agent
• gram-negative, rod-shaped (cocco-bacillus) bacterium
Orientia (Rickettsia) tsutsugamushi.
Budding of O. tsutsugamushi on the cellular surface
• wide phenotypic and genotypic diversity
• reported serotypes are
• does not have a vacuolar membrane and
hence it grows freely in the cytoplasm of
infected cells.
• Cell wall lacks lipopolysaccharide and
peptidoglycan and does not have an outer
slime layer
Karp, Kato, Gilliam, Boryong, Kawazaki
Vector - Primary Reservoir
• Transmitted by bite of infected larvae of the trombiculid mite
Leptotrombidium deliense (“chiggers”)
• feeds on lymph and tissue fluid rather than blood.
• bite of the mite leaves a characteristic black eschar
Earlier it was thought that
rodents were the natural
reservoir of infection, but it
is now believed that mites
are both the vector and the
reservoir.
Natural Reservoir
Grasslands
Areas Around Houses
Rice Fields
The term scrub of scrub
typhus came from the
type of vegetations
(terrain between woods
& clearings) that harbor
the vectors.
Moist Areas: Swamp & Bog
Chigger’s Habitats
Pathogenesis – “Vasculitis like”
Organism divides and
breeds within the
phagocytes
escape from the cell,
back into the
circulation
proliferate on the
endothelium of small
blood vessels
cytokines which
damage endothelial
integrity
fluid leakage,
platelet aggregation,
polymorphs and
monocyte
proliferation
focal occlusive end-
angitis microinfarcts
Incubation Period
• 7–21 days (mean, 10–12 days)
Clinical Presentation – Eschar
… a pathognomonic sign
• A painless papule occurs at the bite site, later ulcerates, & transforms into
a black crust or ‘eschar’ in a variable proportion of patients, the border of
the eschar is surrounded by reddish erythema.
• Difficult to spot in darker individuals; moist intertriginous surfaces may be
missed if not looked into carefully
Clinical Presentation -Eschars
Onset: Appears at the end of the 1st week, lasts
3~7days.
Location: Chest, abdomen, whole trunk, or upper
and lower limbs. rarely involves the face, palms
and soles.
 Initially rash is in the form of pink, blanching,
discrete maculae which subsequently becomes
maculopapular, petechial or hemorrhagic.
Maculopapular Rash
Lymphadenopathy
 Regional lymphadenopathy:
occurs at the end of the 1st week.
localize: the draining lymph node around the primary eschar
characterized by tenderness and enlargement
 Generalized lymphadenopathy: appears 2-3 days later.
Clinical Features
Clinical Presentation - Complications
• More virulent strains of O. tsutsugamushi can cause
Respiratory
• interstitial
pneumonitis
• overwhelming
pneumonia with ARDS
Cardiac
•Toxic myocarditis
Hematological
• Thrombocytopenia
• Pancytopenia
• disseminated
intravascular
coagulation (DIC)
Neuropsychiatric
• Meningitis, Encephalitis
• Cochlear component of 8th nerve
involvement
• Transverse Myelitis
Abdominal
• acute hepatic failure
• acute renal failure
• GI bleeding
• para-aortic, portahepatic and the
splenic hilar lymphadenopathy
Clinical Profile - Comparison
• SYMPTOMS
• FEVER
• 220 (99.5%)
• HEADACHE
• 61(27.6%)
• COUGH
• 39(17.6%)
• VOMITING
• 39(17.6%)
• ALTERED SENSORIUM
• 34(15.4%)
• PAIN ABDOMEN
• 30(13.6%)
• BODYACHES
• 30(13.6%)
• DYSPNEA
• 21(9.5%)
• DECREASED URINE OUTPUT
• 16(7.2%)
• DIARRHOEA
• 12(5.4%)
• CHEST PAIN
• 5(2.3%)
• HEMOPTYSIS
VijayKumar
Et.al
Varghese et.al Subbalaxmi et.al Kedareshwar
et.al
Place/Year 2015/Kolar 2013/Vellore 2013/Andhra 2010/Goa
Patients no. 41 154 176 15
Fever 100% 100% 100% 100%
Myalgia 85% 38% 80%
Headache 78% 66% 52.3%
Vomiting 54.4% 100%
Abdomen Pain 11% 46.7%
Cough 37.3% 53.4% 46.7%
Diarrhea 6.2% 12% 15.9% 26.7%
Altered
Sensorium
2.43% 18% 13.1% 6.7%
Eschar 2.43% 55.9%% 13.1% 13.3%
Clinical Presentation - Complications
Varghese GM, Janardhanan J, Trowbridge P, Peter JV, Prakash JA, Sathyendra S, Thomas K, David TS, Kavitha
ML, Abraham OC, Mathai D. Scrub typhus in South India: clinical and laboratory manifestations, genetic
variability, and outcome. International Journal of Infectious Diseases. 2013 Nov 30;17(11):e981-7.
DDx – “typhus-like illness”
Typhus
(SFG, TG and/or STG)
distinguished only by specific serological tests with
acute and convalescent samples (IFA, IIP, ELISA, RFD) or
PCR assays tests, same treatment for all
Malaria by stained blood films, antigen detection assays
Arbovirus infections
(e.g. dengue, chikungunya)
serological methods (NS1, IgM, IgG assays). Dengue rash
is finer and more erythematous than scrub typhus and
with marked thrombocytopenia
Leptospirosis PCR (full blood) or culture (blood, CSF)
Relapsing fever
(lice or ticks)
demonstration of Borrelia in blood smears, serology or
PCR
Meningococcal disease blood and CSF cultures
Typhoid blood and bone marrow cultures
Viral fevers with macular rash, for example Epstein–Barr virus,
infectious mononucleosis, and primary HIV infection,
distinguished serologically
APPROACH GUIDELINES
The Problems faced by us..
• Diagnosis is greatly hampered by the lack of accurate and accessible
laboratory diagnosis.
• Given the large populations of India and China, the numbers
potentially exposed are enormous.
• With the growth of ecotourism in Asia, more travellers are returning
to non-endemic areas with this disease.
LABORATORY DIAGNOSIS
Weil-Felix test
ELISA based tests, particularly immunoglobulin M (IgM) capture
assays
Molecular diagnosis by PCR
Indirect Immunoperoxidase Assay (IPA)
Immunofluorescence Assay (IFA)
GOLD STANDARD
WEIL FELIX
• Sharing of the antigens between rickettsia and proteus is the basis of
this heterophile antibody test.
• Demonstrates agglutinins to Proteus vulgaris strain OX19, OX2 and
Proteus mirabilis OXK.
• Though this test lacks high sensitivity and specificity but still serves as
a useful and inexpensive diagnostic tool for laboratory diagnosis of
rickettsial disease.
• Should be carried out only after 5-7 days of onset of fever.
Weil Felix Test Interpretation
• Titre of 1:80 is to be considered possible infection.
IgM and IgG ELISA
• ELISA techniques, particularly immunoglobulin M (IgM) capture assays
for serum, are probably the most of sensitive tests available for
rickettsial diagnosis.
• In cases of infection with O. tsutsugamushi,
• a significant IgM antibody titre is observed at the end of 1st week,
• IgG antibodies appear at the end of 2nd week.
WEIL FELIX ELISA
PRINCIPLE HETEROPHILE AGGLUTINATION WITH
PROTEUS ANTIGEN
(OX19, OX2 & OXK)
RECOMBINANT ANTIGEN OF
ORIENTIA
TIME OVERNIGHT 2 HRS
EASE OF
PERFORMING
SIMPLE BUT TIME CONSUMING EASY BUT TECHNICALLY
DEMANDING
COST CHEAP COST EFFECTIVE
NO OF SAMPLES
REQUIRED
PAIRED SERA ;FOUR FOLD RISE SINGLE SERA ;> CUT OFF
RESULT
INTERPRETATION
SUBJECTIVE; NO CONSENSUS ON
SINGLE SIGNIFICANT TITRE
OBJECTIVE; CUT OFF BASED
ON CALCULATION ON
NORMAL SERA
ANTIBODY TESTED MAINLY IgM SEPARATE ASSAYS FOR IgM
AND IgG
SENSITIVITY 30- 60 93-97
SPECIFICITY 60- 90 91-95
Polymerase Chain Reaction
• a rapid and specific test for diagnosis, available only at few centres in
India.
• can be used to detect rickettsial DNA in whole blood and eschar
samples.
• PCR is targeted at the gene encoding the major 56 Kda and/or 47
KdHTRa surface antigen gene.
• The results are best within first week for blood samples because of
presence of rickettsemia in first 7-10 days.
Immunufluoroscence Assay (IFA)
• IFA slide presents antigens from only 3 serotypes namely
Karp, Kato and Gilliam
• Therefore, it is recommended only for research and in
areas where sero-prevalence of rickettsial diseases has
been established
• This is a reference serological method for
diagnosis of Rickettsial Diseases
• considered serological ‘gold standard’; however,
cost and requirement of technical expertise limit
its wide use.
Immunoperoxidase Assay (IPA)
• is a modification of IFA technique that
replaces the fluorochrome with
peroxidase.
• Slide is observed using a bright-field
microscope.
• Staining reaction is positive when O.
tsutsugamushi particles stain light
brown. Control Infected
SERO
LOG
Y
Acute
sensitiv
ity
Sp
ec
ifi
cit
y
Cost/
samp
le
Time Ea
se
Setting Comments
IFA +
+
+
+
+
+
+
+
+
2hours ++ Reference
lab/hospit
al
Serology gold standard, Requires
propagation & purification of BSL3 agents
as antigen for assay, Requires
fluorescence microscope, Standardization
problems & Requires paired samples
(retrospective diagnosis)
IPA +
+
+
+
+
+
+
+
2hours ++
++
Reference
lab/hospit
al
-do- except requires light
microscope only
Weil-
Felix
OXK2
+ ++ + 6-18
hours
++
++
Primary
hospital
•Poor sensitivity for acute
disease
• Requires paired samples
(retrospective diagnosis)
Supportive laboratory Investigations
• WBC count may become elevated to more
than 11,000 / cu. mm.
• Thrombocytopenia (i.e. < 1,00,000/ cu.mm) is
seen in majority of patients.
• Raised Transaminase levels are commonly
observed
• Chest X-Ray showing infiltrates, mostly
bilateral
Before admission
After treatment
Suspected/Clinical case
• Acute undifferentiated febrile illness of 5 days or more with or
without eschar - suspect Rickettsial infection.
• If eschar is present, fever of less than 5 days duration should be
considered as scrub typhus.
• Other presenting features: headache and rash, lymphadenopathy,
multi-organ involvement like liver, lung and kidney involvement.
Probable case
 Points to consider as positive for typhus and spotted fever groups of
Rickettsiae.
A suspected clinical case
titres of 1:80 or above in OX2, OX19 and OXK antigens by Weil
Felix test
optical density (OD) > 0.5 for IgM by ELISA
Confirmed case
Rickettsial DNA detection in eschar samples or whole blood by PCR
Or
Rising antibody titers on acute and convalescent sera detected by
Indirect Immune Fluorescence Assay (IFA) or Indirect
Immunoperoxidase Assay (IPA)
TREATMENT
• Without waiting for laboratory confirmation of the Rickettsial
infection, antibiotic therapy should be instituted when rickettsial
disease is suspected.
• Preantibiotic era -- Mortality was variable , approached ~60%,
• Antibiotic therapy brings about prompt disappearance of the fever
and dramatic clinical improvement.
• Rapid defervescence after antibiotic treatment is so characteristic that
it is used as a diagnostic test for O. tsutsugamushi infection
Primary Health Centre Level
• Less severe cases.....
ADULT CHILDREN PREGNANCY
Doxycycline 200 mg/day in
two divided doses for 7
days
Or
Azithromycin 500 mg in a
single oral dose for 5
days.
Doxycycline 4.5 mg/kg
body weight/day in two
divided doses for 7 days
Or
Azithromycin 10mg/kg body
weight in a single oral dose
for 5 days.
Azithromycin 500 mg in a
single oral dose for 5
days.
Primary Health Centre Level
If presents with Complications
• Refer to secondary or tertiary centre - ARDS, acute renal failure,
meningo encephalitis, multi-organ dysfunction.
• Doxycycline should be initiated before referring the patient.
• In addition to recommended management of community acquired
pneumonia, Doxycycline is to be initiated when scrub typhus is
considered likely.
Secondary and Tertiary Care
• (wherever available) 100mg twice daily in 100 ml normal saline to be
administered as infusion over half an hour initially followed by oral
therapy to complete 7-15 days of therapy.
I.V Doxycycline
• in the dose of 500mg IV in 250 ml normal saline over 1 hour once daily
for 1-2 days followed by oral therapy to complete 5 days of therapy.
I.V Azithromycin
• 50-100 mg/kg/d 6 hourly doses to be administered as infusion over 1
hour initially followed by oral therapy to complete 7-15 days of
therapy.
I.V Chloramphenicol
Prophylaxis
• Recommended under special circumstances where disease is endemic.
• Oral chloramphenicol or tetracycline given once every 5 days for
thirty-five days or weekly doses of doxycycline during and for 6 weeks
after exposure have both been shown to be effective regimens.
• Resistance to antibiotics has been noted in several areas, therefore
prophylaxis with antibiotics cannot be guaranteed.
Vaccine against scrub typhus?
• There is enormous antigenic variation in Orientia tsutsugamushi
strains, and immunity to one strain does not confer immunity to
another
• A vaccine developed for one locality may not be protective in another
locality, because of antigenic variation.
• This complexity continues to hamper efforts to produce a viable
vaccine
PREVENTION
• Protective clothing.
• Insect repellents containing dibutyl phthalate, benzyl benzoate,
diethyl toluamide etc applied to the skin and clothing to prevent
chigger bites.
• Do not sit or lie on bare ground or grass
• Clearing of vegetation and chemical treatment of the soil may help to
break up the cycle of transmission from chiggers to humans to other
chiggers.
CONTROL STRATEGY
Public
Education
Rodent
Control
Habitat
Modification
Case
Identification
&
Treatment
Take home message
Scrub typhus is a re-emerging disease in India.
an important cause of community acquired undifferentiated febrile illness in India.
It has to be considered in the differential diagnosis of sepsis and multiorgan dysfunction
syndrome.
Failure of early diagnosis is associated with significant mortality and morbidity and also leads
to expensive PUO workup.
Search for an eschar in hidden areas of body.
Screening by Weil-Felix & Diagnosis is done by IgM scrub typhus ELISA.
Drug of choice - - - - Doxycycline.

Más contenido relacionado

La actualidad más candente (20)

Scrub typhus
Scrub typhusScrub typhus
Scrub typhus
 
Leptospirosis
LeptospirosisLeptospirosis
Leptospirosis
 
Scrub typhus
Scrub typhusScrub typhus
Scrub typhus
 
Brucellosis ppt
Brucellosis pptBrucellosis ppt
Brucellosis ppt
 
Scrub typhus
Scrub typhus Scrub typhus
Scrub typhus
 
Diptheria
DiptheriaDiptheria
Diptheria
 
Scrub typhus
Scrub  typhusScrub  typhus
Scrub typhus
 
Scrub typhus in India
Scrub typhus in India Scrub typhus in India
Scrub typhus in India
 
Dermatophytes
DermatophytesDermatophytes
Dermatophytes
 
Dengue fever
Dengue feverDengue fever
Dengue fever
 
Epidemiology, prevention, and control of plague
Epidemiology, prevention, and control of plagueEpidemiology, prevention, and control of plague
Epidemiology, prevention, and control of plague
 
Typhoid fever ppt
Typhoid fever pptTyphoid fever ppt
Typhoid fever ppt
 
Ricketssiaceae
RicketssiaceaeRicketssiaceae
Ricketssiaceae
 
Brucella
BrucellaBrucella
Brucella
 
Rickettsial diseases
Rickettsial diseasesRickettsial diseases
Rickettsial diseases
 
Rickettsial fever
Rickettsial feverRickettsial fever
Rickettsial fever
 
Zika virus
Zika virusZika virus
Zika virus
 
Typhus
TyphusTyphus
Typhus
 
Typhus and its management
Typhus and its managementTyphus and its management
Typhus and its management
 
Leishmaniasis (Kala Azar)
Leishmaniasis (Kala Azar)Leishmaniasis (Kala Azar)
Leishmaniasis (Kala Azar)
 

Similar a Scrub typhus 2016 Epidemiology - Symptoms - Diagnosis - Management

Similar a Scrub typhus 2016 Epidemiology - Symptoms - Diagnosis - Management (20)

scrub typhus.pptx
scrub typhus.pptxscrub typhus.pptx
scrub typhus.pptx
 
Scrub Typhus Recent advances
Scrub Typhus Recent advancesScrub Typhus Recent advances
Scrub Typhus Recent advances
 
Malaria ppt final
Malaria ppt finalMalaria ppt final
Malaria ppt final
 
Ricketssia
RicketssiaRicketssia
Ricketssia
 
Rickettsial Infection.pptx
Rickettsial Infection.pptxRickettsial Infection.pptx
Rickettsial Infection.pptx
 
Scrub typhus
Scrub typhusScrub typhus
Scrub typhus
 
RNA VIRAL INFECTIONS .pptx
RNA VIRAL INFECTIONS .pptxRNA VIRAL INFECTIONS .pptx
RNA VIRAL INFECTIONS .pptx
 
Leptospirosis : An Overview
Leptospirosis : An OverviewLeptospirosis : An Overview
Leptospirosis : An Overview
 
Antibiotics in tropical fever in icu.
Antibiotics in tropical fever in icu.Antibiotics in tropical fever in icu.
Antibiotics in tropical fever in icu.
 
Rickettsiae
RickettsiaeRickettsiae
Rickettsiae
 
Zoonotic infections.ppt
Zoonotic infections.pptZoonotic infections.ppt
Zoonotic infections.ppt
 
Scrub typhus spm seminar
Scrub typhus spm seminarScrub typhus spm seminar
Scrub typhus spm seminar
 
Japanese Encephalitis
Japanese Encephalitis Japanese Encephalitis
Japanese Encephalitis
 
DIAGNOSIS AND TREATMENT OF SCRUB THYPUS
DIAGNOSIS AND TREATMENT OF SCRUB THYPUS DIAGNOSIS AND TREATMENT OF SCRUB THYPUS
DIAGNOSIS AND TREATMENT OF SCRUB THYPUS
 
Rickettsial ds
Rickettsial dsRickettsial ds
Rickettsial ds
 
RIKETTSIAL DISEASE IN INDIA [Autosaved].pptx
RIKETTSIAL DISEASE IN INDIA [Autosaved].pptxRIKETTSIAL DISEASE IN INDIA [Autosaved].pptx
RIKETTSIAL DISEASE IN INDIA [Autosaved].pptx
 
Typhoid neo
Typhoid neoTyphoid neo
Typhoid neo
 
4.streptococcus
4.streptococcus4.streptococcus
4.streptococcus
 
Encephalitis ppt
Encephalitis pptEncephalitis ppt
Encephalitis ppt
 
RICKETTSIAL INFECTION.pptx
RICKETTSIAL INFECTION.pptxRICKETTSIAL INFECTION.pptx
RICKETTSIAL INFECTION.pptx
 

Más de Arun Vasireddy

Introduction to Shock & Cardiogenic Shock
Introduction to Shock & Cardiogenic ShockIntroduction to Shock & Cardiogenic Shock
Introduction to Shock & Cardiogenic ShockArun Vasireddy
 
Management of Hepatitis B
Management of Hepatitis BManagement of Hepatitis B
Management of Hepatitis BArun Vasireddy
 
Advances in Management of Hepatitis C
Advances in Management of Hepatitis CAdvances in Management of Hepatitis C
Advances in Management of Hepatitis CArun Vasireddy
 
Interstitial Lung Diseases [ILD] Approach to Management
Interstitial Lung Diseases [ILD] Approach to ManagementInterstitial Lung Diseases [ILD] Approach to Management
Interstitial Lung Diseases [ILD] Approach to ManagementArun Vasireddy
 
Amniotic Fluid Embolism [AFE] Approach to Management
Amniotic Fluid Embolism [AFE] Approach to ManagementAmniotic Fluid Embolism [AFE] Approach to Management
Amniotic Fluid Embolism [AFE] Approach to ManagementArun Vasireddy
 
Approach to Management of Upper Gastrointestinal (GI) Bleeding
Approach to Management of Upper Gastrointestinal (GI) BleedingApproach to Management of Upper Gastrointestinal (GI) Bleeding
Approach to Management of Upper Gastrointestinal (GI) BleedingArun Vasireddy
 
Tachy Arrhythmias - Approach to Management
Tachy Arrhythmias - Approach to ManagementTachy Arrhythmias - Approach to Management
Tachy Arrhythmias - Approach to ManagementArun Vasireddy
 
Pulmonary Oedema - Pathophysiology - Approach & Management
Pulmonary Oedema  - Pathophysiology - Approach & ManagementPulmonary Oedema  - Pathophysiology - Approach & Management
Pulmonary Oedema - Pathophysiology - Approach & ManagementArun Vasireddy
 
Jugular Venous Pressure (JVP) Jugular Venous Pulse
Jugular Venous Pressure (JVP) Jugular Venous PulseJugular Venous Pressure (JVP) Jugular Venous Pulse
Jugular Venous Pressure (JVP) Jugular Venous PulseArun Vasireddy
 
Cardiac Stress Testing Seminar
Cardiac Stress Testing Seminar Cardiac Stress Testing Seminar
Cardiac Stress Testing Seminar Arun Vasireddy
 
Dengue fever Epidemiology - pathogenesis - symptoms - diagnosis - Management ...
Dengue fever Epidemiology - pathogenesis - symptoms - diagnosis - Management ...Dengue fever Epidemiology - pathogenesis - symptoms - diagnosis - Management ...
Dengue fever Epidemiology - pathogenesis - symptoms - diagnosis - Management ...Arun Vasireddy
 
Adrenal gland & Cushing's Disease - Seminar August 2015
Adrenal gland & Cushing's Disease - Seminar August  2015Adrenal gland & Cushing's Disease - Seminar August  2015
Adrenal gland & Cushing's Disease - Seminar August 2015Arun Vasireddy
 

Más de Arun Vasireddy (13)

Introduction to Shock & Cardiogenic Shock
Introduction to Shock & Cardiogenic ShockIntroduction to Shock & Cardiogenic Shock
Introduction to Shock & Cardiogenic Shock
 
Management of Hepatitis B
Management of Hepatitis BManagement of Hepatitis B
Management of Hepatitis B
 
Advances in Management of Hepatitis C
Advances in Management of Hepatitis CAdvances in Management of Hepatitis C
Advances in Management of Hepatitis C
 
Interstitial Lung Diseases [ILD] Approach to Management
Interstitial Lung Diseases [ILD] Approach to ManagementInterstitial Lung Diseases [ILD] Approach to Management
Interstitial Lung Diseases [ILD] Approach to Management
 
Amniotic Fluid Embolism [AFE] Approach to Management
Amniotic Fluid Embolism [AFE] Approach to ManagementAmniotic Fluid Embolism [AFE] Approach to Management
Amniotic Fluid Embolism [AFE] Approach to Management
 
Approach to Management of Upper Gastrointestinal (GI) Bleeding
Approach to Management of Upper Gastrointestinal (GI) BleedingApproach to Management of Upper Gastrointestinal (GI) Bleeding
Approach to Management of Upper Gastrointestinal (GI) Bleeding
 
Tachy Arrhythmias - Approach to Management
Tachy Arrhythmias - Approach to ManagementTachy Arrhythmias - Approach to Management
Tachy Arrhythmias - Approach to Management
 
Pulmonary Oedema - Pathophysiology - Approach & Management
Pulmonary Oedema  - Pathophysiology - Approach & ManagementPulmonary Oedema  - Pathophysiology - Approach & Management
Pulmonary Oedema - Pathophysiology - Approach & Management
 
Jugular Venous Pressure (JVP) Jugular Venous Pulse
Jugular Venous Pressure (JVP) Jugular Venous PulseJugular Venous Pressure (JVP) Jugular Venous Pulse
Jugular Venous Pressure (JVP) Jugular Venous Pulse
 
Cardiac Stress Testing Seminar
Cardiac Stress Testing Seminar Cardiac Stress Testing Seminar
Cardiac Stress Testing Seminar
 
Dengue fever Epidemiology - pathogenesis - symptoms - diagnosis - Management ...
Dengue fever Epidemiology - pathogenesis - symptoms - diagnosis - Management ...Dengue fever Epidemiology - pathogenesis - symptoms - diagnosis - Management ...
Dengue fever Epidemiology - pathogenesis - symptoms - diagnosis - Management ...
 
Adrenal gland & Cushing's Disease - Seminar August 2015
Adrenal gland & Cushing's Disease - Seminar August  2015Adrenal gland & Cushing's Disease - Seminar August  2015
Adrenal gland & Cushing's Disease - Seminar August 2015
 
Osteoporosis Seminar
Osteoporosis Seminar Osteoporosis Seminar
Osteoporosis Seminar
 

Último

Hypersensitivity and its classification .pptx
Hypersensitivity and its classification .pptxHypersensitivity and its classification .pptx
Hypersensitivity and its classification .pptxAkshay Shetty
 
SHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptxSHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptxAbhishek943418
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)MohamadAlhes
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfHongBiThi1
 
Musculoskeletal disorders: Osteoarthritis,.pptx
Musculoskeletal disorders: Osteoarthritis,.pptxMusculoskeletal disorders: Osteoarthritis,.pptx
Musculoskeletal disorders: Osteoarthritis,.pptxraviapr7
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledgeassessoriafabianodea
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..AneriPatwari
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfDivya Kanojiya
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
Units of Radiation Measurements, Quality Specification, Half-Value Thickness,...
Units of Radiation Measurements, Quality Specification, Half-Value Thickness,...Units of Radiation Measurements, Quality Specification, Half-Value Thickness,...
Units of Radiation Measurements, Quality Specification, Half-Value Thickness,...Dr. Dheeraj Kumar
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 
Phytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfPhytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfDivya Kanojiya
 
ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom KidanemariamANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom KidanemariamAkebom Gebremichael
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
Valproic Acid. (VPA). Antiseizure medication
Valproic Acid.  (VPA). Antiseizure medicationValproic Acid.  (VPA). Antiseizure medication
Valproic Acid. (VPA). Antiseizure medicationMohamadAlhes
 

Último (20)

Hypersensitivity and its classification .pptx
Hypersensitivity and its classification .pptxHypersensitivity and its classification .pptx
Hypersensitivity and its classification .pptx
 
SHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptxSHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptx
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
 
Musculoskeletal disorders: Osteoarthritis,.pptx
Musculoskeletal disorders: Osteoarthritis,.pptxMusculoskeletal disorders: Osteoarthritis,.pptx
Musculoskeletal disorders: Osteoarthritis,.pptx
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdf
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
Units of Radiation Measurements, Quality Specification, Half-Value Thickness,...
Units of Radiation Measurements, Quality Specification, Half-Value Thickness,...Units of Radiation Measurements, Quality Specification, Half-Value Thickness,...
Units of Radiation Measurements, Quality Specification, Half-Value Thickness,...
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 
Phytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfPhytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdf
 
JANGAMA VISHA .pptx-
JANGAMA VISHA .pptx-JANGAMA VISHA .pptx-
JANGAMA VISHA .pptx-
 
ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom KidanemariamANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
Valproic Acid. (VPA). Antiseizure medication
Valproic Acid.  (VPA). Antiseizure medicationValproic Acid.  (VPA). Antiseizure medication
Valproic Acid. (VPA). Antiseizure medication
 

Scrub typhus 2016 Epidemiology - Symptoms - Diagnosis - Management

  • 1.
  • 2. Scheme of Presentation Introduction Historical Perspective Epidemiology & Indian Scenario Pathogenesis Clinical features & Complications Approach to the Disease Management Prevention & Control
  • 3. SCRUB TYPHUS - Introduction • Aka., Japanese river fever • known in Japanese folklore to be associated with the jungle mite or chigger, termed ‘tsutsugamushi’ in Japanese • (tsutsuga = disease,harm, noxious and mushi = bug). • is a zoonosis, with humans being accidental, dead end hosts
  • 4. Historical Perspective • Rickettsial infection has been one of the great scourges of mankind, occurring in devastating epidemics during times of war and famine. • Hippocrates in 460 bc used the term typhus, meaning ‘smoke’, to describe the ‘confused state of the intellect – a tendency to stupor’ associated with high fevers.
  • 5. Why is it linked to War ? • Napoleon’s retreat from Moscow was forced by rickettsial disease breaking out among his troops. • Lenin is said to have remarked, in reference to rickettsial disease during Russian revolution,“either socialism will defeat the louse or the louse will defeat the socialism”
  • 6. Major Impact on research during WW2.. • Its impact on immunologically naive Allied troops between 1942 and 1945 resulted in 18 000 cases and 639 deaths (4.0%), as well as an estimated 20 000 cases in Japanese troops. • First batch of scrub typhus vaccine used to inoculate human subjects was dispatched to India for use by the Allied Land Forces, South-East Asia Command, in June 1945. • Leading cause of pyrexia of unknown origin (PUOs) in forces of USA during the VietNam conflict.
  • 7. Indian Scenario • In India, the disease had occurred among troops during the Second World War in Assam and West Bengal, and in the 1965 Indo-Pak war. • There was a resurgence of the disease in 1990 in a unit of an army deployed at the Pakistan border of India. • Occurrence reported from several states in India including Jammu and Kashmir, Himachal Pradesh, Uttarakhand, Bihar, West Bengal, Meghalaya, Rajasthan, Maharashtra, Karnataka, Tamil Nadu and Kerala. • Scrub typhus accounts for upto 50% of undifferentiated fever presenting to hospitals. • It remains a major underdiagnosed(suspected) cause of undifferentiated fever.
  • 8. TsuTsugamushi Triangle South and Southeast Asia, the Asian Pacific rim, Northern Australia Geographic Distribution
  • 9. The Rickettsial diseases Modern classification based on whole-genome analysis… Typhus Group •Epidemic Typhus - R.prowazekki •Murine Typhus - R.typhi •Scrub Typhus - O.tsutsugamushi Spotted Fever Group •Indian tick typhus - R.conorii •Rocky Mountain spotted fever •Rickettsial pox - R.akari others •Q Fever - C.brunetti •Trench Fever - Rochalimaea Quintana
  • 10. Agent • gram-negative, rod-shaped (cocco-bacillus) bacterium Orientia (Rickettsia) tsutsugamushi. Budding of O. tsutsugamushi on the cellular surface • wide phenotypic and genotypic diversity • reported serotypes are • does not have a vacuolar membrane and hence it grows freely in the cytoplasm of infected cells. • Cell wall lacks lipopolysaccharide and peptidoglycan and does not have an outer slime layer Karp, Kato, Gilliam, Boryong, Kawazaki
  • 11. Vector - Primary Reservoir • Transmitted by bite of infected larvae of the trombiculid mite Leptotrombidium deliense (“chiggers”) • feeds on lymph and tissue fluid rather than blood. • bite of the mite leaves a characteristic black eschar
  • 12. Earlier it was thought that rodents were the natural reservoir of infection, but it is now believed that mites are both the vector and the reservoir. Natural Reservoir
  • 13.
  • 14. Grasslands Areas Around Houses Rice Fields The term scrub of scrub typhus came from the type of vegetations (terrain between woods & clearings) that harbor the vectors. Moist Areas: Swamp & Bog Chigger’s Habitats
  • 15. Pathogenesis – “Vasculitis like” Organism divides and breeds within the phagocytes escape from the cell, back into the circulation proliferate on the endothelium of small blood vessels cytokines which damage endothelial integrity fluid leakage, platelet aggregation, polymorphs and monocyte proliferation focal occlusive end- angitis microinfarcts
  • 16. Incubation Period • 7–21 days (mean, 10–12 days)
  • 17. Clinical Presentation – Eschar … a pathognomonic sign • A painless papule occurs at the bite site, later ulcerates, & transforms into a black crust or ‘eschar’ in a variable proportion of patients, the border of the eschar is surrounded by reddish erythema. • Difficult to spot in darker individuals; moist intertriginous surfaces may be missed if not looked into carefully
  • 19. Onset: Appears at the end of the 1st week, lasts 3~7days. Location: Chest, abdomen, whole trunk, or upper and lower limbs. rarely involves the face, palms and soles.  Initially rash is in the form of pink, blanching, discrete maculae which subsequently becomes maculopapular, petechial or hemorrhagic. Maculopapular Rash
  • 20. Lymphadenopathy  Regional lymphadenopathy: occurs at the end of the 1st week. localize: the draining lymph node around the primary eschar characterized by tenderness and enlargement  Generalized lymphadenopathy: appears 2-3 days later.
  • 22. Clinical Presentation - Complications • More virulent strains of O. tsutsugamushi can cause Respiratory • interstitial pneumonitis • overwhelming pneumonia with ARDS Cardiac •Toxic myocarditis Hematological • Thrombocytopenia • Pancytopenia • disseminated intravascular coagulation (DIC) Neuropsychiatric • Meningitis, Encephalitis • Cochlear component of 8th nerve involvement • Transverse Myelitis Abdominal • acute hepatic failure • acute renal failure • GI bleeding • para-aortic, portahepatic and the splenic hilar lymphadenopathy
  • 23. Clinical Profile - Comparison • SYMPTOMS • FEVER • 220 (99.5%) • HEADACHE • 61(27.6%) • COUGH • 39(17.6%) • VOMITING • 39(17.6%) • ALTERED SENSORIUM • 34(15.4%) • PAIN ABDOMEN • 30(13.6%) • BODYACHES • 30(13.6%) • DYSPNEA • 21(9.5%) • DECREASED URINE OUTPUT • 16(7.2%) • DIARRHOEA • 12(5.4%) • CHEST PAIN • 5(2.3%) • HEMOPTYSIS VijayKumar Et.al Varghese et.al Subbalaxmi et.al Kedareshwar et.al Place/Year 2015/Kolar 2013/Vellore 2013/Andhra 2010/Goa Patients no. 41 154 176 15 Fever 100% 100% 100% 100% Myalgia 85% 38% 80% Headache 78% 66% 52.3% Vomiting 54.4% 100% Abdomen Pain 11% 46.7% Cough 37.3% 53.4% 46.7% Diarrhea 6.2% 12% 15.9% 26.7% Altered Sensorium 2.43% 18% 13.1% 6.7% Eschar 2.43% 55.9%% 13.1% 13.3%
  • 24. Clinical Presentation - Complications Varghese GM, Janardhanan J, Trowbridge P, Peter JV, Prakash JA, Sathyendra S, Thomas K, David TS, Kavitha ML, Abraham OC, Mathai D. Scrub typhus in South India: clinical and laboratory manifestations, genetic variability, and outcome. International Journal of Infectious Diseases. 2013 Nov 30;17(11):e981-7.
  • 25. DDx – “typhus-like illness” Typhus (SFG, TG and/or STG) distinguished only by specific serological tests with acute and convalescent samples (IFA, IIP, ELISA, RFD) or PCR assays tests, same treatment for all Malaria by stained blood films, antigen detection assays Arbovirus infections (e.g. dengue, chikungunya) serological methods (NS1, IgM, IgG assays). Dengue rash is finer and more erythematous than scrub typhus and with marked thrombocytopenia Leptospirosis PCR (full blood) or culture (blood, CSF) Relapsing fever (lice or ticks) demonstration of Borrelia in blood smears, serology or PCR Meningococcal disease blood and CSF cultures Typhoid blood and bone marrow cultures Viral fevers with macular rash, for example Epstein–Barr virus, infectious mononucleosis, and primary HIV infection, distinguished serologically
  • 27. The Problems faced by us.. • Diagnosis is greatly hampered by the lack of accurate and accessible laboratory diagnosis. • Given the large populations of India and China, the numbers potentially exposed are enormous. • With the growth of ecotourism in Asia, more travellers are returning to non-endemic areas with this disease.
  • 28. LABORATORY DIAGNOSIS Weil-Felix test ELISA based tests, particularly immunoglobulin M (IgM) capture assays Molecular diagnosis by PCR Indirect Immunoperoxidase Assay (IPA) Immunofluorescence Assay (IFA) GOLD STANDARD
  • 29. WEIL FELIX • Sharing of the antigens between rickettsia and proteus is the basis of this heterophile antibody test. • Demonstrates agglutinins to Proteus vulgaris strain OX19, OX2 and Proteus mirabilis OXK. • Though this test lacks high sensitivity and specificity but still serves as a useful and inexpensive diagnostic tool for laboratory diagnosis of rickettsial disease. • Should be carried out only after 5-7 days of onset of fever.
  • 30. Weil Felix Test Interpretation • Titre of 1:80 is to be considered possible infection.
  • 31. IgM and IgG ELISA • ELISA techniques, particularly immunoglobulin M (IgM) capture assays for serum, are probably the most of sensitive tests available for rickettsial diagnosis. • In cases of infection with O. tsutsugamushi, • a significant IgM antibody titre is observed at the end of 1st week, • IgG antibodies appear at the end of 2nd week.
  • 32. WEIL FELIX ELISA PRINCIPLE HETEROPHILE AGGLUTINATION WITH PROTEUS ANTIGEN (OX19, OX2 & OXK) RECOMBINANT ANTIGEN OF ORIENTIA TIME OVERNIGHT 2 HRS EASE OF PERFORMING SIMPLE BUT TIME CONSUMING EASY BUT TECHNICALLY DEMANDING COST CHEAP COST EFFECTIVE NO OF SAMPLES REQUIRED PAIRED SERA ;FOUR FOLD RISE SINGLE SERA ;> CUT OFF RESULT INTERPRETATION SUBJECTIVE; NO CONSENSUS ON SINGLE SIGNIFICANT TITRE OBJECTIVE; CUT OFF BASED ON CALCULATION ON NORMAL SERA ANTIBODY TESTED MAINLY IgM SEPARATE ASSAYS FOR IgM AND IgG SENSITIVITY 30- 60 93-97 SPECIFICITY 60- 90 91-95
  • 33. Polymerase Chain Reaction • a rapid and specific test for diagnosis, available only at few centres in India. • can be used to detect rickettsial DNA in whole blood and eschar samples. • PCR is targeted at the gene encoding the major 56 Kda and/or 47 KdHTRa surface antigen gene. • The results are best within first week for blood samples because of presence of rickettsemia in first 7-10 days.
  • 34. Immunufluoroscence Assay (IFA) • IFA slide presents antigens from only 3 serotypes namely Karp, Kato and Gilliam • Therefore, it is recommended only for research and in areas where sero-prevalence of rickettsial diseases has been established • This is a reference serological method for diagnosis of Rickettsial Diseases • considered serological ‘gold standard’; however, cost and requirement of technical expertise limit its wide use.
  • 35. Immunoperoxidase Assay (IPA) • is a modification of IFA technique that replaces the fluorochrome with peroxidase. • Slide is observed using a bright-field microscope. • Staining reaction is positive when O. tsutsugamushi particles stain light brown. Control Infected
  • 36. SERO LOG Y Acute sensitiv ity Sp ec ifi cit y Cost/ samp le Time Ea se Setting Comments IFA + + + + + + + + + 2hours ++ Reference lab/hospit al Serology gold standard, Requires propagation & purification of BSL3 agents as antigen for assay, Requires fluorescence microscope, Standardization problems & Requires paired samples (retrospective diagnosis) IPA + + + + + + + + 2hours ++ ++ Reference lab/hospit al -do- except requires light microscope only Weil- Felix OXK2 + ++ + 6-18 hours ++ ++ Primary hospital •Poor sensitivity for acute disease • Requires paired samples (retrospective diagnosis)
  • 37. Supportive laboratory Investigations • WBC count may become elevated to more than 11,000 / cu. mm. • Thrombocytopenia (i.e. < 1,00,000/ cu.mm) is seen in majority of patients. • Raised Transaminase levels are commonly observed • Chest X-Ray showing infiltrates, mostly bilateral Before admission After treatment
  • 38. Suspected/Clinical case • Acute undifferentiated febrile illness of 5 days or more with or without eschar - suspect Rickettsial infection. • If eschar is present, fever of less than 5 days duration should be considered as scrub typhus. • Other presenting features: headache and rash, lymphadenopathy, multi-organ involvement like liver, lung and kidney involvement.
  • 39. Probable case  Points to consider as positive for typhus and spotted fever groups of Rickettsiae. A suspected clinical case titres of 1:80 or above in OX2, OX19 and OXK antigens by Weil Felix test optical density (OD) > 0.5 for IgM by ELISA
  • 40. Confirmed case Rickettsial DNA detection in eschar samples or whole blood by PCR Or Rising antibody titers on acute and convalescent sera detected by Indirect Immune Fluorescence Assay (IFA) or Indirect Immunoperoxidase Assay (IPA)
  • 41. TREATMENT • Without waiting for laboratory confirmation of the Rickettsial infection, antibiotic therapy should be instituted when rickettsial disease is suspected. • Preantibiotic era -- Mortality was variable , approached ~60%, • Antibiotic therapy brings about prompt disappearance of the fever and dramatic clinical improvement. • Rapid defervescence after antibiotic treatment is so characteristic that it is used as a diagnostic test for O. tsutsugamushi infection
  • 42. Primary Health Centre Level • Less severe cases..... ADULT CHILDREN PREGNANCY Doxycycline 200 mg/day in two divided doses for 7 days Or Azithromycin 500 mg in a single oral dose for 5 days. Doxycycline 4.5 mg/kg body weight/day in two divided doses for 7 days Or Azithromycin 10mg/kg body weight in a single oral dose for 5 days. Azithromycin 500 mg in a single oral dose for 5 days.
  • 43. Primary Health Centre Level If presents with Complications • Refer to secondary or tertiary centre - ARDS, acute renal failure, meningo encephalitis, multi-organ dysfunction. • Doxycycline should be initiated before referring the patient. • In addition to recommended management of community acquired pneumonia, Doxycycline is to be initiated when scrub typhus is considered likely.
  • 44. Secondary and Tertiary Care • (wherever available) 100mg twice daily in 100 ml normal saline to be administered as infusion over half an hour initially followed by oral therapy to complete 7-15 days of therapy. I.V Doxycycline • in the dose of 500mg IV in 250 ml normal saline over 1 hour once daily for 1-2 days followed by oral therapy to complete 5 days of therapy. I.V Azithromycin • 50-100 mg/kg/d 6 hourly doses to be administered as infusion over 1 hour initially followed by oral therapy to complete 7-15 days of therapy. I.V Chloramphenicol
  • 45. Prophylaxis • Recommended under special circumstances where disease is endemic. • Oral chloramphenicol or tetracycline given once every 5 days for thirty-five days or weekly doses of doxycycline during and for 6 weeks after exposure have both been shown to be effective regimens. • Resistance to antibiotics has been noted in several areas, therefore prophylaxis with antibiotics cannot be guaranteed.
  • 46. Vaccine against scrub typhus? • There is enormous antigenic variation in Orientia tsutsugamushi strains, and immunity to one strain does not confer immunity to another • A vaccine developed for one locality may not be protective in another locality, because of antigenic variation. • This complexity continues to hamper efforts to produce a viable vaccine
  • 47. PREVENTION • Protective clothing. • Insect repellents containing dibutyl phthalate, benzyl benzoate, diethyl toluamide etc applied to the skin and clothing to prevent chigger bites. • Do not sit or lie on bare ground or grass • Clearing of vegetation and chemical treatment of the soil may help to break up the cycle of transmission from chiggers to humans to other chiggers.
  • 49. Take home message Scrub typhus is a re-emerging disease in India. an important cause of community acquired undifferentiated febrile illness in India. It has to be considered in the differential diagnosis of sepsis and multiorgan dysfunction syndrome. Failure of early diagnosis is associated with significant mortality and morbidity and also leads to expensive PUO workup. Search for an eschar in hidden areas of body. Screening by Weil-Felix & Diagnosis is done by IgM scrub typhus ELISA. Drug of choice - - - - Doxycycline.

Notas del editor

  1. Occurrence reported from several states in India including Jammu and Kashmir, Himachal Pradesh, Uttarakhand, Bihar, West Bengal, Meghalaya, Rajasthan, Maharashtra, Karnataka, Tamil Nadu and Kerala.
  2. They maintain the infection throughout their life stages and has transovarial transmission. The infection passes from the egg to the larva or adult - transtadial transmission. Thus, chigger mite populations can autonomously maintain their infectivity over long periods of time.
  3. Presentation
  4. rickettsial pox, cutaneous anthrax